CN102608325B - 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) - Google Patents
心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) Download PDFInfo
- Publication number
- CN102608325B CN102608325B CN201110215292.7A CN201110215292A CN102608325B CN 102608325 B CN102608325 B CN 102608325B CN 201110215292 A CN201110215292 A CN 201110215292A CN 102608325 B CN102608325 B CN 102608325B
- Authority
- CN
- China
- Prior art keywords
- fabp
- reagent
- buffer
- fatty acid
- binding protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004816 latex Substances 0.000 title claims abstract description 26
- 229920000126 latex Polymers 0.000 title claims abstract description 26
- 238000012360 testing method Methods 0.000 title claims abstract description 17
- 238000004879 turbidimetry Methods 0.000 title claims abstract description 5
- 102000011026 Fatty Acid Binding Protein 3 Human genes 0.000 title claims description 56
- 108010062715 Fatty Acid Binding Protein 3 Proteins 0.000 title claims description 56
- 230000002708 enhancing effect Effects 0.000 title claims description 4
- 102000030914 Fatty Acid-Binding Human genes 0.000 title abstract description 9
- 108091022862 fatty acid binding Proteins 0.000 title abstract description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 31
- 238000001514 detection method Methods 0.000 claims abstract description 20
- 239000000872 buffer Substances 0.000 claims abstract description 18
- 210000002966 serum Anatomy 0.000 claims abstract description 13
- 239000003381 stabilizer Substances 0.000 claims abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 239000003755 preservative agent Substances 0.000 claims abstract description 7
- 230000002335 preservative effect Effects 0.000 claims abstract description 7
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 11
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 239000004471 Glycine Substances 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000000834 fixative Substances 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- -1 Wherein Substances 0.000 claims description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 2
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical compound ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000001718 carbodiimides Chemical class 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 229920001213 Polysorbate 20 Polymers 0.000 claims 2
- 244000309466 calf Species 0.000 claims 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 230000021523 carboxylation Effects 0.000 claims 1
- 238000006473 carboxylation reaction Methods 0.000 claims 1
- 238000005660 chlorination reaction Methods 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 101100226596 Gallus gallus FABP gene Proteins 0.000 abstract description 6
- 238000002965 ELISA Methods 0.000 abstract description 4
- 238000003556 assay Methods 0.000 abstract description 4
- 238000011088 calibration curve Methods 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 229910017053 inorganic salt Inorganic materials 0.000 abstract description 3
- 239000011324 bead Substances 0.000 abstract description 2
- 238000010790 dilution Methods 0.000 abstract description 2
- 239000012895 dilution Substances 0.000 abstract description 2
- 239000008213 purified water Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 230000007812 deficiency Effects 0.000 abstract 1
- 229960001438 immunostimulant agent Drugs 0.000 abstract 1
- 239000003022 immunostimulating agent Substances 0.000 abstract 1
- 230000003308 immunostimulating effect Effects 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 210000002381 plasma Anatomy 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 108010010803 Gelatin Chemical group 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229920000159 gelatin Chemical group 0.000 description 3
- 239000008273 gelatin Chemical group 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 150000004668 long chain fatty acids Chemical class 0.000 description 3
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical group FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000003680 myocardial damage Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000003118 sandwich ELISA Methods 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 101800000263 Acidic protein Proteins 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000003150 biochemical marker Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical group [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 210000005059 placental tissue Anatomy 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110215292.7A CN102608325B (zh) | 2012-02-24 | 2012-02-24 | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110215292.7A CN102608325B (zh) | 2012-02-24 | 2012-02-24 | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102608325A CN102608325A (zh) | 2012-07-25 |
CN102608325B true CN102608325B (zh) | 2016-08-24 |
Family
ID=46525864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110215292.7A Active CN102608325B (zh) | 2012-02-24 | 2012-02-24 | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102608325B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102788880A (zh) * | 2012-08-16 | 2012-11-21 | 北京恩济和生物科技有限公司 | 一种心型脂肪酸结合蛋白检测试剂盒及其制备方法 |
CN103123319B (zh) * | 2012-12-20 | 2015-04-15 | 武汉生之源生物科技有限公司 | 心型脂肪酸结合蛋白含量检测试剂盒及其制备方法 |
CN103063830B (zh) * | 2012-12-21 | 2016-04-13 | 杭州茂天赛科技有限公司 | 一种elisa预包被酶标板的制备方法 |
CN103163306B (zh) * | 2013-02-05 | 2015-06-17 | 北京九强生物技术股份有限公司 | 25羟维生素d检测试剂盒及其制备方法 |
CN103760358A (zh) * | 2013-11-12 | 2014-04-30 | 赵铁铭 | 一种用于检测冯维勒布兰德因子的试剂及其制备方法和应用 |
CN105911297B (zh) * | 2016-07-07 | 2018-03-16 | 宏葵生物(中国)有限公司 | 胶乳增强免疫比浊法检测心型脂肪酸结合蛋白的试剂盒 |
CN105954523A (zh) * | 2016-07-14 | 2016-09-21 | 宏葵生物(中国)有限公司 | 一种心肌肌钙蛋白i检测试剂盒 |
CN106442355A (zh) * | 2016-09-29 | 2017-02-22 | 浙江达美生物技术有限公司 | 心型脂肪酸结合蛋白的测定试剂及其制备方法 |
CN107860930A (zh) * | 2017-11-10 | 2018-03-30 | 苏州康和顺医疗技术有限公司 | 一种心型脂肪酸结合蛋白的免疫比浊检测试剂和方法 |
CN117491646A (zh) * | 2023-11-13 | 2024-02-02 | 深圳上泰生物工程有限公司 | 一种心型脂肪酸结合蛋白的检测试剂盒及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3012666B2 (ja) * | 1990-05-28 | 2000-02-28 | 大日本製薬株式会社 | 心筋梗塞の判定方法 |
CA2244326C (en) * | 1997-08-11 | 2006-03-28 | Shinichi Eda | Microparticle enhanced light scattering agglutination assay and microparticle reagents therefor |
US20080175191A1 (en) * | 2004-02-23 | 2008-07-24 | Siemens Aktiengesellschaft | Method, Intermediate Station and Central Control Unit For the Packet-Switched Data Transmission in a Self-Organizing Radio Network |
CN100476432C (zh) * | 2005-12-19 | 2009-04-08 | 孟衍建 | 精子结合抗体检测试剂及其制备方法 |
-
2012
- 2012-02-24 CN CN201110215292.7A patent/CN102608325B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102608325A (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102608325B (zh) | 心型脂肪酸结合蛋白(h-fabp)测定试剂盒(胶乳增强免疫比浊法) | |
US7150995B2 (en) | Methods and systems for point of care bodily fluid analysis | |
CN102628864B (zh) | 胶乳增强免疫比浊法测定血清或尿液中心脏型脂肪酸结合蛋白的试剂盒 | |
AMINO et al. | Measurment of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases | |
CN102680698B (zh) | 中性粒细胞明胶酶相关脂质运载蛋白(ngal)测定试剂盒(胶乳增强免疫比浊法) | |
CN102841206B (zh) | 肌钙蛋白T(Troponin-T,TNT)测定试剂盒 | |
US20220113322A1 (en) | Rapid measurement of total vitamin d in blood | |
EP0017224A1 (en) | Method and reagent for counteracting lipemic interference | |
CN105352958A (zh) | 总25-羟基维生素d检测试剂盒 | |
CN107422113A (zh) | 抗环瓜氨酸肽抗体的检测方法 | |
CN108152512A (zh) | 肝素结合蛋白检测试剂盒及其制备方法 | |
Yamamoto et al. | Automated homogeneous liposome-based assay system for total complement activity | |
CN102421799B (zh) | 用于高分子脂联素分析的新型单克隆抗体及其应用 | |
US8058011B2 (en) | Method for the measurement of endocrine substances in an analyte | |
Cayzer et al. | An evaluation of two new haemagglutination tests for the rapid diagnosis of autoimmune thyroid diseases. | |
CN109187971A (zh) | 神经元特异性烯醇化酶化学发光免疫检测试剂盒及其制备方法 | |
CN106324251A (zh) | 小片段BMG抗体的制备方法及β2‑微球蛋白检测试剂盒 | |
EP1069432B1 (en) | METHOD FOR EXAMINING IgA NEPHROPATHY | |
JPH10160734A (ja) | イムノアッセイ用較正/対照用配合物 | |
Hood | A–Z of clinical chemistry: a guide for the trainee | |
CN105988001A (zh) | 一种测定非对称二甲基精氨酸浓度的试剂盒及方法 | |
CN107860930A (zh) | 一种心型脂肪酸结合蛋白的免疫比浊检测试剂和方法 | |
CN116203221A (zh) | 疏水性干扰物及其制备方法和应用 | |
CN107533054A (zh) | 免疫测定方法以及用于所述方法的测定试剂 | |
CN112485453A (zh) | 一种测定糖化血红蛋白的液相层析试剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 210031 building E, building 10, Spark Road, No. four, Spark Road, Nanjing hi tech Development Zone, Jiangsu, China Applicant after: NANJING NORMAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 5, 210029 building, 66-1 software building, Majiagou industrial district, Nanjing District, Yuhuatai, Jiangsu Applicant before: NANJING NORMAN BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: He Shibiao Document name: Notification of Passing Examination on Formalities |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 197 Yaogu Avenue, Jiangbei New District, Nanjing City, Jiangsu Province, 211899 Patentee after: Nanjing Norman Biotechnology Co.,Ltd. Country or region after: China Address before: 210031 4th floor, e building, talent building, No.10 Xinghuo Road, high tech Development Zone, Nanjing City, Jiangsu Province Patentee before: NANJING NORMAN BIOLOGICAL TECHNOLOGY Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |